@SMosteoru

Cardiologist passionate about research

Timişoara, România
Joined September 2018
Female power United in Prevention! Listen to the great ideas the presidents of the ESC Associations have shared in an amazing session at #ESCPrev2025 #escprevmotions @EAPCPresident @denisamuraru @PTBuketAkinci @AnastasiaSMihai
1
13
2
38
12,669
Svetlana Mosteoru retweeted
🫀Fear of cardiac symptoms may become a barrier to recovery. A systematic review of 26 studies (n=9,628) found heart-focused anxiety in 15–49% of patients with CVD, linked to exercise avoidance and poorer outcomes. 🔗 doi.org/10.1093/eurjpc/zwag5…
1
6
1
13
1,047
Svetlana Mosteoru retweeted
🤰🫀 Hyperlipidaemia in pregnancy: physiology or cardiovascular risk? A timely review of peripartum lipid changes, maternal & fetal outcomes, treatment options, and key evidence gaps. 🔗 doi.org/10.1093/eurjpc/zwaf3…
6
9
324
Svetlana Mosteoru retweeted
Younger age at first diagnosis is strongly associated with lower risk of subsequent events in patients with cerebrovascular disease (stroke) and in women with peripheral artery disease or abdominal aortic aneurysm 📖 doi.org/10.1093/eurjpc/zwag0… @escardio @AboyansV @SilCastelletti
5
10
330
Svetlana Mosteoru retweeted
In this population-based cohort, standard modifiable CV risk factors status significantly impacted long-term but not short-term mortality following MI 📖 doi.org/10.1093/eurjpc/zwaf2… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic
1
5
11
392
Svetlana Mosteoru retweeted
This systematic review and meta-analysis suggests that LDL-C-lowering therapies may offer a greater benefit in preventing first-time MI compared with recurrent MI 📖 doi.org/10.1093/eurjpc/zwaf3… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic
2
26
95
5,089
Our second event in this year’s EAS Advanced Courses on non-classical risk factors series will take place in Prague, Czech Republic. The application process is now open. Join us to learn about the potential role of non-classical factors including chronic inflammation, metabolic disturbances, gut microbiota, psychosocial stress, and environmental influences in cardiovascular disease risk and progression. Register here: eas.to/NCRFCZReg
2
4
292
Our EAS Advanced Courses on non-classical risk factors are back! While traditional risk factors such as high blood pressure, elevated cholesterol, smoking, and diabetes are well recognised, emerging evidence highlights the potential role of non-classical factors - including chronic inflammation, metabolic disturbances, gut microbiota, psychosocial stress, and environmental influences - in cardiovascular disease risk and progression. Join us in Athens, Greece, for the first event in the 2026 series, and register now: eas.to/NCRFGRReg
3
8
343
Svetlana Mosteoru retweeted
An interesting session on the final morning of #ESCCongress 2026 🫀 Residual risk beyond LDL-C: achieving LDL-C targets is only part of the story. Lp(a), persistent inflammation and cardiometabolic risk may help identify the patients who remain at risk — and increasingly provide targets for intervention. Great perspectives on Lp(a), colchicine and GLP-1 therapies presented by great faculty. @escardio @TokgozogluLale @KoKoMaung_ @GalTsaban @SMosteoru #preventivecardiology
1
5
192
Svetlana Mosteoru retweeted
A landmark moment for preventive cardiology during the #ESCCongress 2026: the first-ever ESC Guidelines dedicated to Cardiac Rehabilitation. A comprehensive, multidisciplinary and patient-centred rehabilitation takes centre stage — with individualized exercise, risk-factor management, shared decision-making and new approaches to delivery. @escardio @KoKoMaung_ @GalTsaban @SMosteoru #preventivecardiology
1
2
167
Svetlana Mosteoru retweeted
🔥 Hot Line 11 at #ESCCongress 🫀 An important question in our oldest NSTEMI patients: does everyone ≥80 years need routine invasive management? EVAOLD challenges the “one-size-fits-all” approach, evaluating a selective invasive strategy guided by ischemia testing versus systematic coronary angiography. A highly relevant trial for everyday clinical decision-making. @escardio @KoKoMaung_ @GalTsaban @SMosteoru
2
5
172
Svetlana Mosteoru retweeted
Thirty years of #EUROASPIRE! This evening in Munich, @escardio and NIPC mark the 30th anniversary of EUROASPIRE with researchers, national coordinators and clinical teams who have contributed to the programme over three decades. EUROASPIRE video⬇️ vimeo.com/1222128014?share=c…
1
6
247
New in #EJPC: ✅In both men and women, BMI change during puberty is positively associated with blood pressure and the risk of hypertension in adult life 📕 Read more: ow.ly/HOoA50ZH0tr @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic
11
25
2,086
Svetlana Mosteoru retweeted
Wait… what do ESC Young Professionals Chair @cfcamm & our #ESCMotions teammate @rafavidalperez do in their free time at #ESCCongress? 👀 Practise saving lives, of course! 🫀🙌 We caught them brushing up on their resuscitation skills at the European Resuscitation Council (ERC) CPR workshop station in Hall B1! Want to join the action? 📍Hall B1 📍FREE, 90-minute hands-on BLS & ALS refresher workshops 📍Practise with expert instructors; from high-quality CPR & AED use to teamwork during resuscitation 📍ERC certificate of attendance provided after the congress Still time to join today, 30 August: 🫀BLS: 14:00-15:30 🫀ALS: 16:00-17:30 Places are limited, with final registration on-site on a first-come, first-served basis. Bring your teamwork; & give those lifesaving skills a workout! 💪 Full programme & pre-registration: escardio.org/events/congress… #ESCMotions #ESCCongress @escardio @corneliacrm @_antocannata @KardiologieHH @DrMarthaGulati @SMosteoru @Massimi78530343 @drmilicaa @jozinetm @Sarah_Moharem
5
16
1,106
Svetlana Mosteoru retweeted
Just presented at #ESCCongress 2026 ✅ and simultaneously 📕 in the #EJPC ⤵️ Sport type 🏋‍♂️ 🏃‍♀️‍➡️ 🏊‍♀️ alone does not reliably predict distinct cardiac phenotypes in athletes 📑academic.oup.com/eurjpc/arti…
7
10
701
EuroASPIRE 30 years anniversary #ESCCongress – at Feldkirchen, Deutschland
2
10
249
Svetlana Mosteoru retweeted
Just presented at #ESCCongress 2026 ✅ and simultaneously 📕 in the #EJPC ⤵️ In 18,924 patients with #ACS of ODYSSEY OUTCOMES trial, baseline Lp(a) was not inversely associated with risk of serious bleeding🩸 📑academic.oup.com/eurjpc/arti…
2
5
7
558
Svetlana Mosteoru retweeted
Just presented at #ESCCongress 2026✅ and simultaneously 📕 in the #EJPC ⤵️ Advanced cardiac diagnostics 🩻 was associated with a higher likelihood of a determined etiologic diagnosis in MINOCA ❤️‍🩹 📑academic.oup.com/eurjpc/arti…
7
12
331
Svetlana Mosteoru retweeted
Just presented at #ESCCongress 2026 ✅ and simultaneously 📕 in the #EJPC⤵️ Higher exercise capacity (per 10-Watt ⬆️ ) was associated a lower risk of death in 🧔‍♂️(⬇️18%) and 👩 (⬇️33%) 📑 academic.oup.com/eurjpc/arti…
4
8
321
Svetlana Mosteoru retweeted
Transforming cardiology together, where does AI take us next?🫀🤖🚀 I caught up with no other than @mvaduganathan for #ESCMotions to talk about AI in cardiovascular care And what a plenty of energy at #ESCCongress! 🎤✨ Watch our conversation👇 @Massimi78530343 @rafavidalperez @corneliacrm @drmilicaa @SMosteoru @BirkhoelzerS @SotiriaLiori @HanCardiomd @_antocannata @escardio
11
27
2,459
Svetlana Mosteoru retweeted
EUROASPIRE VI brings 27 countries together to answer the same question: are prevention guidelines being implemented in everyday care? Today, the EUROASPIRE VI Steering Group met at #ESCCongress 2026. Read more about #EUROASPIRE: nipc.ie/research/euroaspire/ @escardio @GalwayCMNHS
1
8
372